Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.

作者: Maija-Liisa Laakso , Niki Lindblom , Lea Leinonen , Markus Kaski

DOI: 10.1016/J.SLEEP.2006.09.006

关键词: PolysomnographySleep disorderMelatoninDark therapyPlaceboSleep onsetCircadian rhythmPsychologyInternal medicineEndocrinologyActigraphy

摘要: Abstract Objective: We studied whether the endogenous melatonin patterns in adult patients with developmental brain disorders have any role response to exogenous given as a sleep-promoting medicine. Methods: Participants included 15 adults (18–60 years, five females) of varying etiologies, motor handicaps, and long-term history sleep problems. According 24-h serum melatonin, were divided into two subgroups: lower higher secretors. The pretreatment disorder was characterized by structured interview, ambulatory polysomnography 7-day wrist actigraphy. Patients received 1, 3, or 6 mg fast-release tablets, each for 4 weeks increasing order, at constant time 30 min before desired onset. Similarly, placebos different codes during 3 × 4 weeks. actigraphy repeated end drug period. Outcome measures six parameters non-parametric circadian rhythm analysis. Drug effects 40 confounding/modulating factors evaluated applying two-level regression analyses co-variables. Results: Exogenous decreased fragmentation rest–activity rhythm, increased day/night ratio activity advanced onset rest on more pronounced than secretors melatonin. Other contributing blindness some features original (disrupted cyclicity architecture reported daytime somnolence). Conclusions: consolidated fragmented about half patients. Low levels night predicted improvement drug. Higher doses not effective lowest dose.

参考文章(63)
H. Niederhofer, W. Staffen, A. Mair, Klaus Pittschieler, Retraction Journal of Autism and Developmental Disorders. ,vol. 33, pp. 469- 472 ,(2003) , 10.1023/A:1025027231938
Nina Buscemi, , Ben Vandermeer, Rena Pandya, Nicola Hooton, Lisa Tjosvold, Lisa Hartling, Glen Baker, Sunita Vohra, Terry Klassen, , Melatonin for treatment of sleep disorders. Evidence report/technology assessment (Summary). pp. 1- 7 ,(2004) , 10.1037/E439412005-001
William C. Dement., Thomas Roth, Meir H. Kryger, Principles and Practice of Sleep Medicine ,(1989)
James Emery Jan, Maureen Eleanor O'Donnell, Use of melatonin in the treatment of paediatric sleep disorders Journal of Pineal Research. ,vol. 21, pp. 193- 199 ,(1996) , 10.1111/J.1600-079X.1996.TB00286.X
T. A. B. Snijders, Roel J. Bosker, Multilevel analysis : an introduction to basic and advanced multilevel modeling Published in <b>2012</b> in Los Angeles London by SAGE. ,(2011)
I.V. Zhdanova, R.J. Wurtman, J. Wagstaff, Effects of a low dose of melatonin on sleep in children with Angelman syndrome. Journal of Pediatric Endocrinology and Metabolism. ,vol. 12, pp. 57- 67 ,(1999) , 10.1515/JPEM.1999.12.1.57
Louise Phillips, Richard E Appleton, Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Developmental Medicine & Child Neurology. ,vol. 46, pp. 771- 775 ,(2004) , 10.1017/S001216220400132X